T. González Ferrero

Should PRECISE-DAPT be included for long-term prognostic stratification of diabetic patients with NSTEACS?

P. Zuazola, A. Cordero, F. Gude Sampedro, 2021, Acta Diabetologica.

Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19

I. Amat-Santos, J. González-Juanatey, J. S. San Román, 2021, Cardiology journal.

Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis

I. Amat-Santos, J. González-Juanatey, J. S. San Román, 2022, Medicina Clínica (English Edition).

Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis

I. Amat-Santos, J. González-Juanatey, J. S. San Román, 2021, Medicina Clínica.

Removal of the intermediate risk group in the latest European guidelines for NSTEACS: is it justified?

J. González-Juanatey, A. Cordero, B. Alvarez-Alvarez, 2021, Revista espanola de cardiologia.

Prognostic benefit from an early invasive strategy in patients with non-ST elevation acute coronary syndrome (NSTEACS): evaluation of the new risk stratification in the NSTEACS European guidelines

P. Zuazola, A. Cordero, F. Gude Sampedro, 2021, Clinical Research in Cardiology.

Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein Isolation

S. Eiras, E. Álvarez, J. García-Seara, 2023, International journal of molecular sciences.